Who owns TRAVERE THERAPEUTICS INC (TVTX?
- CUSIP Number: 89422gaa5
Tip: Access positions for across all investors
Analyze quarterly positions in Travere Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Travere Therapeutics stock
Who bought or sold TRAVERE THERAPEUTICS INC (TVTX this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Wolverine Asset Management | 45M | $29M | 0% | Sep 2023 |
|
D. E. Shaw & Co | 41M | $26M | 0% | Sep 2023 |
|
Braidwell | 28M | $18M | 0% | Sep 2023 |
|
Highbridge Capital Management | 27M | $17M | 279% | Sep 2023 |
|
UBS O'Connor | 25M | $16M | 0% | Sep 2023 |
|
Lazard Asset Management | 24M | $16M | -13% | Sep 2023 |
|
Capstone Investment Advisors | 23M | $15M | -47% | Sep 2023 |
|
Aviva | 23M | $15M | 28% | Sep 2023 |
|
Citigroup | 20M | $13M | 33% | Sep 2023 |
|
Silverback Asset Management | 13M | $8.1B | 100% | Sep 2023 |
|
Segantii Capital Management | 7.5M | $4.9M | -6% | Sep 2023 |
|
Morgan Stanley | 3.1M | $2.0M | 93% | Sep 2023 |
|
Readystate Asset Management | 3.0M | $1.9M | -67% | Sep 2023 |
|
Jane Street | 2.7M | $1.8M | -13% | Sep 2023 |
|
Point72 Asset Management | 2.6M | $1.7M | -70% | Sep 2023 |
|
BlackRock | 2.2M | $1.4M | 22% | Sep 2023 |
|
Linden Advisors | 1.5M | $963M | -89% | Sep 2023 |
|
Lion Point Capital | 1.0M | $648k | 100% | Sep 2023 |
|
Leucadia National Corporation | 500k | $323k | 100% | Sep 2023 |
|
Caas Capital Management | 500k | $317k | 0% | Sep 2023 |
|
Nomura Holdings | 480k | $4.3M | -18% | Sep 2023 |
|
Jpmorgan Chase & Co | 125k | $81k | 0% | Sep 2023 |
|
Context Capital Management | 41k | $27M | 41% | Sep 2023 |
|
Who sold out of Travere Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Centiva Capital | Jun 2023 | 2.5M | $2.0M |
Laurion Capital Management | Jun 2023 | 1.5M | $1.2M |